← 返回

肺癌中 CIBERSORT 方法的免疫浸润分析

英文原题:Immune Infiltration Analysis with the CIBERSORT Method in Lung Cancer.

查看英文原题

Immune Infiltration Analysis with the CIBERSORT Method in Lung Cancer.

PubMed 2022/03/18(内容时间) Dis Markers

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

本文数据揭示,LC 中免疫浸润的细胞成分可能存在细微差异,而这些差异可能是预后结果和治疗反应的重要决定因素。

研究思路结论见上方概要

肺癌(LC)的免疫浸润与临床结果密切相关。然而,过去的研究尚未阐明构成免疫反应的功能不同的细胞类型的多样性。

在本研究中,基于去卷积算法(CIBERSORT)和临床注释的表达谱,我们团队全面研究了502例LC样本和49例正常样本中存在的肿瘤浸润免疫细胞(TIICs)。评估了22个免疫细胞亚组的比例,以确定每种细胞类型与生存及对化学疗法反应之间的关系。

因此,配对肿瘤与癌前组织之间的免疫浸润谱发生显著变化,且这种变化能够描述个体间的多样性。在所研究的细胞亚群中,缺乏静息树突状细胞或滤泡辅助性T(Tfh)细胞数量减少的癌症与不良预后相关。对不同分期LC与22种免疫细胞亚群之间的相关性分析显示,LC中14种免疫细胞的数量与肿瘤分期显著相关。静息树突状细胞和滤泡辅助性T细胞的高表达预示更好的预后价值,单因素分析证明这两种TIIC与患者预后显著相关。

展开英文摘要原文

Immune infiltration of lung cancer (LC) is tightly related to clinical results. Nevertheless, past researches have not elucidated the diversities of functionally different cellular types making up the immunoresponse.

In the present research, on the foundation of a deconvolution algorithm (CIBERSORT) and clinically annotated expression profiles, our team studied the tumor-infiltrating immune cells (TIICs) presenting in 502 LC samples and 49 normal samples in a comprehensive way. The fraction of 22 immunocyte subgroups was assessed to identify the relationship among every cellular type and survival and reaction to chemical therapies.

Consequently, profiles of immunity infiltration change remarkably between paired tumor and precancerous tissues, and the change can describe the diversity of individuals. Of the cellular subgroups studied, cancers without dendritic resting cells or with a decreased quantity of follicular helper T (Tfh) cells were related to the poor prognosis. Correlation analysis between different stages of LC and 22 immune cell subpopulations revealed that the amount of 14 immune cells in LC was remarkably related to tumor stage. The high expression of resting dendritic cells and follicular helper T cells predicted better prognostic value, and univariate analyses proved that two TIICs were significantly associated with patients' prognosis.

To sum up, the data herein reveal that there may be subtle differences in the cell constituents of the immune infiltrate in LC, and those diversities may be vital determinating factors of prognostic results and reactions to therapies.

论文信息

作者
Guan M、Jiao Y、Zhou L
第一作者单位
Cancer Center, The First Hospital of Jilin University, Changchun 130031, China.China
通讯作者单位
Department of Radiology, The First Hospital of Jilin University, Changchun 130031, China.China
期刊
Disease markers2022
原文标识
PubMed 35340416 · DOI 10.1155/2022/3186427